Literature DB >> 17673212

Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation.

Tetsuhiro Chiba1, Yun-Wen Zheng, Kaoru Kita, Osamu Yokosuka, Hiromitsu Saisho, Masafumi Onodera, Hiroyuki Miyoshi, Masayuki Nakano, Yoh Zen, Yasuni Nakanuma, Hiromitsu Nakauchi, Atsushi Iwama, Hideki Taniguchi.   

Abstract

BACKGROUND & AIMS: Transformed hematopoietic stem/progenitor cells with an enhanced or acquired self-renewal capability function as leukemic stem cells. In a variety of solid cancers, stem/progenitor cells could be also targets of carcinogenesis. However, it remains unclear whether disruption of stem cell function directly contributes to cancer initiation. We sought to elucidate the mechanisms of self-renewal in hepatic stem/progenitor cells and the relation between stem cell function and hepatocarcinogenesis.
METHODS: Functional analyses of polycomb-group protein Bmi1 and Wnt/beta-catenin, the molecules that are responsible for the self-renewal capability of many types of stem cells, were conducted in c-Kit(-)CD29(+)CD49f(+/low)CD45(-)Ter-119(-) hepatic stem/progenitor cells using retrovirus- or lentivirus-mediated gene transfer. The tumorigenicity of these cells transduced with the indicated retroviruses was also assessed by transplantation into nonobese diabetic/severe combined immunodeficient mice.
RESULTS: Forced expression of Bmi1 and constitutively active beta-catenin mutant similarly promoted the self-renewal of hepatic stem/progenitor cells. The transplantation of Bmi1- or beta-catenin-transduced cells clonally expanded from single hepatic stem/progenitor cells produced tumors, which exhibited the histologic features of combined hepatocellular and cholangiocarcinoma.
CONCLUSIONS: These observations imply that the dysregulated self-renewal of hepatic stem/progenitor cells serves as an early event in hepatocarcinogenesis, and they highlight the important roles of Bmi1 and the Wnt/beta-catenin pathway in regulating the self-renewal of normal or cancer stem cells in liver.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17673212     DOI: 10.1053/j.gastro.2007.06.016

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  78 in total

Review 1.  Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.

Authors:  J U Marquardt; V M Factor; S S Thorgeirsson
Journal:  J Hepatol       Date:  2010-05-31       Impact factor: 25.083

Review 2.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 3.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

Review 4.  Stem cells in hepatocarcinogenesis: evidence from genomic data.

Authors:  Jens U Marquardt; Snorri S Thorgeirsson
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 5.  New promising drug targets in cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2010-03-23       Impact factor: 7.851

6.  Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts via activation of the Hedgehog signaling pathway.

Authors:  Xiao-Rong Pan; Ying-Ying Jing; Wen-Ting Liu; Zhi-Peng Han; Rong Li; Yang Yang; Jing-Ni Zhu; Xiao-Yong Li; Pei-Pei Li; Li-Xin Wei
Journal:  Cell Cycle       Date:  2017-05-31       Impact factor: 4.534

Review 7.  In search of liver cancer stem cells.

Authors:  Stephanie Ma; Kwok Wah Chan; Xin-Yuan Guan
Journal:  Stem Cell Rev       Date:  2008-07-29       Impact factor: 5.739

8.  Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.

Authors:  Shao-Jie Chen; Yin-Ting Chen; Lin-Juan Zeng; Qiu-Bo Zhang; Guo-da Lian; Jia-Jia Li; Ke-Ge Yang; Chu-Mei Huang; Ya-Qing Li; Zhong-Hua Chu; Kai-Hong Huang
Journal:  Tumour Biol       Date:  2016-03-08

9.  Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.

Authors:  Xiao Li; Zhuochao Zhang; Guoying Lin; Yuanxing Gao; Zhen Yan; Heliang Yin; Bingyi Sun; Fangyuan Wang; Haijun Zhang; Hong Chen; Dayong Cao
Journal:  Tumour Biol       Date:  2016-03-07

10.  The CD133+CD44+ precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma.

Authors:  Yun-Wen Zheng; Tomonori Tsuchida; Taiki Shimao; Bin Li; Takanori Takebe; Ran-Ran Zhang; Yu Sakurai; Yasuharu Ueno; Keisuke Sekine; Naoto Ishibashi; Makiko Imajima; Takuji Tanaka; Hideki Taniguchi
Journal:  Stem Cells Dev       Date:  2014-06-26       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.